期刊名称：TECHNOLOGY IN CANCER RESEARCH & TREATMENT
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Technology in Cancer Research and Treatment welcomes manuscripts from active investigators involved in technologies devoted to early diagnosis, treatment, and palliation of cancer. The Journal will include both experimental and theoretical investigations. Among the topics that will be covered are MRI, including functional MRI, spiral CT, PET, optical spectroscopy, computer-aided reconstruction of tumors, computer-aided drug design, stereotactic radiosurgery, cryosurgery, brachytherapy, electroporation, photodynamic therapy, gene therapy, cancer vaccine, proteomics, and genomics, as they impact cancer research and treatment. Special emphasis will be given to non-invasive techniques. The Journal publishes original articles, express communications, opinion pieces, and timely reviews.
Instructions to Authors
Optional Open Access Policy for TCRT
When an article is published under "Open Access," it , in full text, full image, and searchable form, becomes universally available in digital form, free of charge to anyone in the world. The authors, the publisher, and the right holders grant the right to use, reproduce, and disseminate the work in digital form to all users.
The availability of full text articles in fully searchable form under open access enables the various internet search engines and crawlers to go through the article and index the results. This may increase the probability of other researchers becoming aware of the work.
Open access treats the cost of publication as part of the research project, and it is estimated that the current cost is US $1,500 per article.
The authors of articles in TCRT may elect to have their articles published under "Open Access," provided the cost of publication (US $1,500) is paid in advance. This policy applies to articles already published or for future submissions. If open access option is not exercised, the articles will be published in the traditional manner, in print and online versions.
When an article is published in TCRT under Open Access, the following will happen:
At the TCRT web site (http://www.tcrt.org), a full text/full image, html version with a search engine will appear, and this will be accessible to anyone without any logins or payments.
Without logging in or paying a fee, a visitor can download the full text/full image PDF version of the article as it appeared in the print version.
Open Access articles will be identified by a special insignia in the Table of Contents at the TCRT web site.
Any supplementary material associated with an article will be available, free of charge, at the TCRT web site.
Adenine Press will not hold the copy rights for the digital version of "Open Access" TCRT articles that appear at the journal web site.
Examples of Open Access Articles can be found at the following links:
http://www.tcrt.org/index.cfm?d=3015&c=4125&p=11938&do=detail
http://www.tcrt.org/index.cfm?d=3015&c=4102&p=11434&do=detail
http://www.tcrt.org/index.cfm?d=3018&c=4150&p=12289&do=detail
http://www.tcrt.org/index.cfm?d=3018&c=4153&p=12353&do=detail
http://www.tcrt.org/index.cfm?d=3018&c=4130&p=12032&do=detail
http://www.tcrt.org/index.cfm?d=3015&c=4125&p=11945&do=detail
For further information please email steve@adeninepress.com, phone: 518-456-0784; fax: 518-452-4955
Download Open Access Authorization & Payment Form
Subjects Covered
Technology in Cancer Research and Treatment welcomes manuscripts from active investigators involved in technologies devoted to early diagnosis, treatment, and palliation of cancer. The Journal will include both experimental and theoretical investigations. Among the topics that will be covered are MRI, including functional MRI, spiral CT, PET, optical spectroscopy, computer-aided reconstruction of tumors, computer-aided drug design, stereotactic radiosurgery, cryosurgery, brachytherapy, electroporation, photodynamic therapy, gene therapy, cancer vaccine, proteomics, and genomics, as they impact cancer research and treatment. Special emphasis will be given to non-invasive techniques. The Journal publishes original articles, express communications, opinion pieces, and timely reviews.
Where to Submit the Manuscript
The manuscript should be submitted as pdf or MS Word format to the editor-in-chief via e-mail (mukti@albany.edu). If a hard copy is required, the editor will request for one.
Review by Referees
All articles will be subject to review by expert referees to determine scientific soundness. Authors are welcome to suggest five possible referees. The editors may or may not consult the recommended referees. If referees are suggested, please include their complete mailing address, phone, and fax numbers and e-mail address.
Category of Articles
Regular Articles: There is no page limitation. For papers that do not undergo extensive revision, the normal publication time is between three and five months.
Accelerated Communication: Timely discoveries need to be communicated at an accelerated pace; that is, within two and three months. Authors wishing to have their manuscripts published as an accelerated communication should indicate this in the covering letter along with the arguments for immediate communication. Accelerated articles normally should not exceed 12 pages including tables and figures. Editors and referees will make the final determination on classifying an article for accelerated status.
Opinions: Opinion pieces will be published as soon as possible. Submissions should not exceed four journal pages. Papers in this section should present a new vision or perspective of recent developments. They may also address critically recent publications from any journal. In the latter case, the criticized authors will be given a chance to write a prompt response. Articles in this section should address unsolved controversies arising in current research. Authors interested in submitting in "Opinions" should e-mail their articles to mukti@albany.edu. Document should be in MS Word and figures in tiff or jpeg.
Revised Versions
The final revised version of the manuscript should be submitted in MS Word format as well as in pdf via e-mail to the editor-in-chief. In the revised version, the authors should highlight the altered sections. Also, the authors should write a covering letter answering point-by-point the questions raised by the reviewers. The figures should be stored as tiff or jpg format.
Fonts and Special Characters
For text, tables and figure legends, please use the font "Times"; for special characters and symbols, use the "Symbol" font or use appropriate key board equivalents under "Times". Please refrain from using the "insert" menu in Microsoft word for special characters and symbols.
Manuscript Organization
The manuscript must be organized in the following manner: Abstract, Introduction, Materials and Methods, Results and Discussion, Acknowledgments, References. The abstract must strictly follow TCRT style and formatting (Click here for an example). The Materials and Method section should give sufficient detail so experiments can be repeated. The subheading "Results and Discussion" in many instances can be replaced by a set of appropriate subheadings that reflect the contents. In the Abstract section, if there is a reference, please provide the complete reference (rather than the number in the reference section). This is required because Chemical Abstracts and Biological Abstracts use the abstracts from the Journal directly. The legends for figures and tables should be grouped together and should appear at the end of the manuscript. Do not paste legends under the appropriate diagrams.
Title Page
Do not use all CAPITAL LETTERS for any entry in the title page; use both lower and upper cases. The title page must contain:
Title in upper and lower case.
Authors, their degrees and affiliation. When authors originate from different institutions, please include a complete mailing address for each institution.
The author to whom correspondence should be addressed must be indicated by an asterisk along with his/her phone, and e-mail data. This will appear as a footnote to page 1 of the article.
A short running title
Collection of key words.
Abbreviations.
Figures and Tables
Using red to indicate the appropriate place where the figures and tables should be inserted. Figure and table numbers must be marked clearly on all copies. Figures are numbered using the Arabic system (i.e., 1, 2, 3 ...) and tables are numbered in the Roman manner (i.e., I, II, III ...). Figure and table numbers must be marked clearly on all copies.
References and Footnotes
References are numbered sequentially and the numbers must appear in parenthesis in the text. Footnotes should be in lower case (i.e., a, b, c. . .) and added at the end of the reference section. Books and journals are treated equally, their names and volume numbers should appear in regular italics. Some examples of the arrangement of references (1, 2) are given below:
Ojha, R. P., Dhingra, M. M., Sarma, M. H., Shibata, M., Farrar, M., Turner, C. J., Sarma. R. H. DNA bending and sequence-dependent backbone conformation: NMR and computer experiments. Eur. J. Biochem. 265, 35-53 (1999).
Setlik, R. F. , Ojha, R. P., Dhingra, M. M., Sarma, M. H., , Shibata, M., Kazim, A. L., Ornstein, R. L., Rein, R., Turner, C. J., Sarma, R. H. 750 MHz and computer experiments on an anti-HIV-1 hammerhead ribozyme complex with a 17-mer DNA substrate analog of HIV-1 gag RNA, in Structure, Dynamics, Interactions And Expression of Biological Macromolecules, The Proceedings of the Tenth Conversation, Vol. 2, pp 163-174. Eds., R. H. Sarma and M. H. Sarma, Adenine Press, Schenectady, NY (1998).
Equations Mathematical equations should be created clearly and numbered in the text. The number should appear in square brackets, i.e., [ ] to distinguish them from reference numbers. The Journal follows IUPAC-IUB nomenclature.
No Page Charges
There are no page charges. Once a manuscript has been accepted by an Editor as scientifically sound, the Journal will publish the article at its expense. However, there may be a charge for certain special services. For example, a laboratory which has grant support must pay the cost of color illustrations. For laboratories without grant support, the Journal will pay for these services provided they are essential for the article. The minimum charge for processing color plates is $400 and will accommodate 2 to 4 color plates (depending on size) in a page. For more than one color page, please contact Adenine Press.
Page Proofs
The authors will be furnished with pdf files. It is the author's responsibility to correct proofs and return changes immediately. If the proofs are not received by the due date, Adenine Press will proof read and move forward with production. A reasonable number of corrections from the author will be incorporated at no charge. All other alterations and corrections will be billed to the author. Authors of articles accepted for publication in the Journal must sign a standard copyright transfer form. Authors are completely responsible for obtaining the permission to reproduce materials such as figures, and copyrighted text by a publisher/agency other than Adenine Press.
Responsibility of the Board
The Board-of-Editors, and the Publisher Adenine Press will have discharged responsibility once an article is published. They are not responsible for any or part of the statements and claims made by authors in their articles.
It is understood that the communicating author, collectively represents all authors of an article, and that he/she has obtained permission form all authors to communicate the article in their behalf. Adenine Press, Technology in Cancer Research and Treatment or its Board is not responsible, for any negligence or omissions by the communicating author.
Editorial Board
Editor-in-Chief
Mukti H. Sarma, Ph. D.
Associate Director, Center for Biochemistry & Biophysics
Department of Chemistry, University at Albany-SUNY
Albany, NY. USA, 12222
phone: 518-442-4431, fax: 518-442-3462
Email: mukti@albany.edu
John R. Adler, M.D.
R-205, Stanford University Medical Center
300 Pasteur Drive
Stanford, CA 94305
Phone: (650) 723-5573, Fax: (650) 723-7813
Email: jradler@stanford.edu
Abass Alavi, M.D.
Chief, Division of Nuclear Medicine
Hospital of the University of Pennsylvania
3400 Spruce St, Philadelphia, PA 19104
Phone: 215-662-3069, Fax: 215-349-5843
Email: alavi@rad.upenn.edu
Robert Alfano, Ph. D.
Director, Institute of Ultrafast
Spectroscopy & Laser
The City College of New York
New York NY 10031
Phone: 212-650-5531
Fax: 212-650-5530
Email: alfano@scisun.sci.ccny.cuny.edu
Hugh Barr, M.D.
Professor, Cranfield Postgraduate Medical School
Gloucestershire Royal Hospital, Great Western Road
Gloucester GL1 3NN, U.K
Phone: +44 (0) 8454 226679
Fax :+44 (0) 8454 226813
Email. hugh.barr@gloucr-tr.swest.nhs.uk, or prof.barr@themail.co.uk
Carl A. K. Borrebaeck, Ph.D.
Chairman, Dept. of Immunotechnology
Lund University
P. O. Box 7031, SE-220 07 Lund, Sweden
Phone: +46-46-222-4320, +46-46-222-9613 (direct)
Fax: +46-46-222-4200
Email: carl.borrebaeck@immun.lth.se
Julio E. Celis, Ph.D.
Scientific Director, Danish Cancer Society
Institute of Cancer Biology
Strandboulevarden 49
DK-2100 Copenhagen, Denmark
Phone: +45 3525 7363 Fax: +45 3525 7721
Email: jec@cancer.dk
Laurence Clarke, Ph.D.
Branch Chief, Imaging Technology Development Branch
Biomedical Imaging Program, EPN, Room 6054
6130 Executive Blvd.,
Rockville, MD 20852-7412
Phone: 301 496 9531, Fax: 301 480 3507
Email: lclarke@mail.nih.gov
James H. Doroshow, M.D.
Director, Medical Oncology
City of Hope Comprehensive Cancer Center
1500 E. Duarte Road
Duarte CA 91010
Phone: 626-359-8111, Fax: 626-9305461
Email: JDoroshow@coh.org
Nathan A. Ellis, Ph.D.
Director, Lab of Cancer Susceptibility
Gastroenterology Section, University of Chicago
5841 S. Maryland Ave. MC4080, Chicago, IL 60637
Phone-773-702-7868, Fax-773-702-5790
Email: nellis@medicine.bsd.uchicago.edu
Andrew A. Gage, M.D.
Professor of Surgery Emeritus
School of Medicine & Biomedical Sciences
State University of New York at Buffalo
Buffalo, New York 14214
Email: aagee70@aol.com
Roberto Gambari, Ph.D.
Department of Biochemistry and Molecular Biology
Ferrara University
Via Luigi Borsari n.46
44100 Ferrara, Italy
Phone +39-532-291448
Fax: +39-532-202723
Email: gam@dns.unife.it
Sanjiv Sam Gambhir M.D., Ph.D.
Director, Molecular Imaging Program at Stanford (MIPS)
Head, Division of Nuclear Medicine
Professor, Department of Radiology and Bio-X Program
Stanford University, 318 Campus Drive, E150A
Stanford, CA 94305-5427
Phone: 650-725-2309, Fax: 650-724-4948
Email: sgambhir@stanford.edu
Daila S. Gridley, Ph.D.
Chan Shun Pavilion
Room A-1010, 11175 Campus Street
Loma Linda University School of Medicine
Loma Linda, CA 92354, USA
Phone: 909-558-8361, Fax: 909-558-0825
Email: dgridley@dominion.llumc.edu
Uwe Haberkorn, Ph.D.
Dept. of Nuclear Medicine
University of Heidelberg
Im Neuenheimer Feld 400
69120 Heidelberg, Germany
Phone: D-6221-567731, Fax: D-6221-565473
Email: Uwe_haberkorn@med.uni-heidelberg.de
Garret M. Hampton, Ph.D.
Principal Scientist
Genomics Institute of the Novartis Research Foundation
3115 Merryfield Row
San Diego, CA 92121
Phone: 858-812-1522, Fax: 858-812-1570
Email: hampton@gnf.org
Samir Hanash, M.D., Ph.D.
Fred Hutchinson Cancer Research Center
1100 Fairview Ave
M5-C800
Seattle, WA 98109
Phone: (206) 667-7091
Email: shanash@fhcrc.org
Richard Heller, Ph.D.
Associate Professor, Department of Surgery
University of South Florida, College of Medicine
12901 Bruce B. Downs Blvd., MDC Box 16
Tampa, Florida 33612-4799
Tel: 813 974-3065, Fax: 813 974-2669
Email: rheller@hsc.usf.edu
Claudia I. Henschke, M.D., Ph.D.
Weill Cornell Medical School
Professor
Dept. of Radiology
New York Presbyterian Hospital
New York, NY 10021
Email: chensch@med.cornell.edu
David Isaacson, Ph.D.
Rensselaer Polytechnic Institute
Department of Mathematics
Troy, NY 12180
Phone: 518-276-6900
Email: isaacd@rpi.edu
Andreas H. Jacobs, M.D.
Laboratory for Gene Therapy and Molecular Imaging
MPI for Neurological Research and
Department of Neurology, University of Cologne
Gleuelerstr. 50, 50931 Cologne, Germany
Email: andreas.jacobs@pet.mpin-koeln.mpg.de
Samie R. Jaffrey, M.D., Ph.D.
Department of Pharmacology
Cornell University Weill Medical College
1300 York Ave., Box 70
New York, NY 10021
Phone: 212-746-6243, Fax: 212-746-5596
Email: jaffrey@alum.mit.edu
Kewal K. Jain, M.D.
Pharmabiotech
Blaesiring 7
4057 Basel
Switzerland
Phone & Fax: +4161 692 4461
Email: jain@pharmabiotech.ch
Hana Kovarova, Ph.D.
Inst. of Animal Physiology and Genetics
Academy of Sciences of the Czech Republic
277 21 Libechov, Czech Republic
Phone: 42 (0) 206- 639-564
Fax: 42 (0) 206-697-186
Email: kovarova@iapg.cas.cz
Lester Kwock, Ph.D.
Professor of Radiology
University of North Carolina
School of Medicine
Chapel Hill, NC 27599-7515
Phone: (919) 966-2845, Fax: (919) 966-2859
Email: kwock@med.unc.edu
David Larson, M.D., Ph.D.
Professor, Department of Radiation Oncology
505 Parnassus Ave
University of California San Francisco
San Francisco, CA 94143-0226
Phone: 415-353-8900, Fax: 415-353-8679
Email: larson@radonc17.ucsf.edu
Jonathan S. Lewin, M.D.
Professor, Radiology, Oncology, & Neurological Surgery
Director, MRI, Dept of Radiology
University Hospitals of Cleveland
Case Western Reserve University
Phone: 216-844-8785, Fax: 216-844-8062
Email: lewin@uhrad.com
Jay Loeffler, M.D.
Andres Soriano Professor and Chair
Department of Radiation Oncology
Massachusetts General Hospital
Boston, MA 02114
Phone: 617-724-1548, Fax: 617-724-9532
Email: jloefeler@partners.org
Kenneth Lundstrom, Ph.D.
Regulon Inc.
Chief Scientific Officer,
Chemin des Croisettes 22,
CH-1066 Epalinges
SwitzerlandPhone: 41-79-279 2167
Email: superscientist@hotmail.com
Donald C. Malins, Ph.D., D.Sc.
Principal Scientist and Director
Biochemical Oncology Program
Pacific Northwest Research Institute
720 Broadway, Seattle, WA 98122
Phone: 206-726-1240, Fax: 206-726-1235
Email: dmalins@pnri.org
William M. Mendenhall, M.D.
Shands Cancer Center
Box 100385
Gainesville. FL 32610-0385, USA
Phone: 352-265-0287
Fax 352-265-0759
Email: mendewil@shands.ufl.edu
Paulette McCormick, Ph.D.
Professor and Director
Center for Comparative Functional Genomics
Director of Cancer Genetics, VA Medical Center
University at Albany SUNY
EC, Suite A202, One University Place, Rensselaer, NY 12144
Phone: 518-591-8301, Fax: 518-525-2799
Email: pmc@albany.edu
Subir Nag, M.D.
Chief of Brachytherapy
Ohio State University Hospital
300 West Tenth Avenue, #072.
Columbus, OH 43210, USA
Phone: 614-293-3246,
Fax: 614-293-4044
Email: nag.1@osu.edu
Orhan Nalcioglu, Ph.D., FIEEE, FAAPM, FISMRM
Director, Health Sciences Research Imaging Center
College of Medicine
University of California
Irvine, CA 92697-5020
Phone: 949-824-6001, Fax: 949-824-3481
Email: nalci@uci.edu
Dattatreyudu Nori, M.D., F.A.C.R.
Chief, Radiation Oncology
Weill Cornell Medical College
New York Presbyterian Hospital
New York NY 10021
Phone: 212:746-3679, Fax: 212-746-3888
Email: dnori@nyp.org
Harald Paganetti, Ph.D.
Assistant Professor of Radiation Oncology
Massachusetts General Hospital & Harvard Medical School
55 Fruit Street, Boston
MA 02114, USA
Phone: 617-726-5847, Fax: 617-724-0368
Email: hpaganetti@partners.org
Lech Papiez, Ph.D.
Director of Radiation Physics
Department of Radiation Oncology
Indiana University School of Medicine
535 Barnhill Dr., RT083, Indianapolis IN 46202, USA
Phone: 317-274-1188; Fax: 317-274-2486
Email: lpapiez@iupui.edu
William F. Regine, M.D.
Chairman, Dept. of Radiation Oncology
University of Maryland, University Center
22 South Greene St.
Rm GGK0101
Baltimore, MD 21201-1595, USA
Email: wregi002@umaryland.edu
Thomas Ried, M.D.
Genetics Department, Division of Clinical Sciences
National Cancer Institute/NIH
Bldg. 9, Rm. 1N105, 9 Memorial Drive
Bethesda, MD 20892
Phone: 301-594-3118, Fax: 301-435-4428
Email: riedt@mail.nih.gov
Berkman Sahiner, Ph.D.
CGC B2102
1500 E. Medical Center Dr.
Ann Arbor, MI 48109-0904
Phone: 734-647-7429
Fax: 734- 647-8557
Email: berki@umich.edu
Michael L. Salgaller, Ph.D.
Toucan Capital Corp.
7600 Wisconsin Ave., 7th Floor
Bethesda, MD 20814
Phone: 240-497-4060
Fax: 240-497-4065
Email: msalgaller@toucancapital.com
Mukti H. Sarma, Ph.D.
Associate Director, CBB
Department of Chemistry
University at Albany
Phone: 518-442-4431, Fax: 518-442-3462
Email: mukti@albany.edu
Daniel Scherman, Ph.D.
Facult¨¦ de Pharmacie, Unit¨¦ INSERM
CNRS de Pharmacologie Chimique et G¨¦n¨¦tique
4, avenue de l'Observatoire, 75270 Paris Cedex 06, France
Phone: 33 (0)1 53 73 95, Fax : 33 (0)1 43 26 69 18
Email: daniel.scherman@pharmacie.univ-paris5.fr
Christian P. Schultz, Ph.D.
Director of Molecular Imaging
Siemens Medical, Business Development
MGH - Center of Molecular Imaging. Research
Bld 149, 13th Street, R5416, Charlestown, MA 02129
Phone: 978-239-8360, Email: Christian.P.Schultz@siemens.com
Eva M. Sevick-Muraca, Ph.D.
Professor of Chemical Engineering and Chemistry
The Photon Migration Laboratory
Texas A&M University
College Station, Texas 77843-3573
Phone: (979)-458-3206, Fax: (979)-458-1011
Email: eva-m-sevick@tamu.edu
Keshav K. Singh, Ph.D.
Associate Professor of Cancer Genetics &
Molecular and Cellular Biophysics & Biochemistry
Roswell Park Cancer Institute
Cell and Virus Building, Room # 247
Elm and Carlton Streets, Buffalo, NY, 14263
Phone: 716-845-8017, Fax: 716-845-1047
E-mail: keshav.singh@roswellpark.org
Luis Souhami, M.D.
Professor and Associate Director
Division of Oncology/ Radiation Oncology
McGill University,
1650 Cedar Avenue
Montreal, Quebec H3G 1A4, Canada
Phone: 514 934 8040; FAX: 514 934 8220
Email: luis.souhami@muhc.mcgill.ca
Marcus D. Seemann, M.D.
Associate Professor of Radiology
Department of Nuclear Medicine
Technical University of Munich
Ismaninger Strasse 22, D - 81675 Munich, Germany
Tel. ++49 89 4140 2971, Fax ++49 89 4140 4841
Email: m.seemann@lrz.tum.de
Lloyd M. Smith, Ph.D.
Department of Chemistry
University of Wisconsin, Madison
1101 University Ave.
Madison WI, 53706
Phone: 608 263 2594, Fax: 608 265 6780
Email: smith@chem.wisc.edu
Robert D. Timmerman, M.D.
Dept. of Radiation Oncology
Indiana University School of Medicine
535 Barnhill Drive, RT041, Indianapolis, IN 46202
Phone: (317)274-1190; Fax: (317)274-2486
Email: rtimmerm@iupui.edu
Elizabeth R. Unger, Ph.D., M.D.
Centers for Disease Control & Prevention
1600 Clifton Road, MSG-G41
Atlanta GA 30333, USA
Phone: 404-639-3533, Fax: 404-639-2799
Email: eru0@cdc.gov
Carston R. Wagner, Ph.D.
Dept. of Medicinal Chemistry, College of Pharmacy
University of Minnesota
Minneapolis, MN 55455
Phone: (612) 625-2614, Fax: (612) 624-0139
Email: wagne003@tc.umn.edu
James S. Welsh, MS, MD
Department of Human Oncology
University of Wisconsin, Madison
UW Cancer Center, 410 Dewey Street
Wisconsin Rapids, WI 54494, USA
Phone: 715-421-7442, E-mail: welsh@humonc.wisc.edu
Mark B. Williams, Ph.D.
University of Virginia
Department of Radiology
Box 800170
Charlottesville, VA 22908
Phone: 434-982-4422, Fax: 434-924-9435
Email: mbwilliams@virginia.edu
Cedric Yu, Ph.D.
Department of Radiation Oncology
University of Maryland Medical System
22 S. Greene St.
Baltimore MD 21029, USA
Phone: 410-328-0324 or 410-328-7074
Fax: 410-328-2618, Email: cyu002@umaryland.edu
Wei Zhang, Ph.D.
Cancer Genomics Core Lab.
Dept. Pathology, Box 85
The University of Texas M. D. Anderson Cancer Center
1515 Holcombe Blvd., Houston, TX 77030
Phone: 713-745-1103, Fax: 713-792-5549
Email: wzhang@mail.mdanderson.org
Nikolai Zhelev, PhD, CBiol, EurProBiol, FIBiol
Professor of Medical Biotechnology and Director, CMCBR
School of Contemporary Sciences
University of Abertay Dundee
Bell Street, Dundee DD1 1HG, Scotland, UK
Tel: +44(0)1382 308000, Fax: +44(0)1382 308117
Email: Nikolai.Zhelev@abertay.ac.uk
|
刊名字顺( Alphabetical List of Journals):
返回页首 